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a b s t r a c t
Virus genomes are condensed and packaged inside stable proteinaceous capsids that serve to protect
them during transit from one cell or host organism, to the next. During virus entry, capsid shells are
primed and disassembled in a complex, tightly-regulated, multi-step process termed uncoating. Here we
compare the uncoating-programs of DNA viruses of the pox-, herpes-, adeno-, polyoma-, and
papillomavirus families. Highlighting the chemical and mechanical cues virus capsids respond to, we
review the conformational changes that occur during stepwise disassembly of virus capsids and how
these culminate in the release of viral genomes at the right time and cellular location to assure successful
replication.
& 2015 Published by Elsevier Inc.
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Introduction
All viruses – enveloped and non-enveloped – protect their
genome inside a proteinaceous shell referred to as a capsid or core.
Its main function is to protect the genome during the extracellular
phase of the virus life cycle. It thereby assists efﬁcient cell-to-cell
transmission, organ-to-organ spread, and host-to-host propagation.
Each of these extracellular environments confront the virus particle
and its precious cargo with a different subset of challenges. These
might include UV irradiation, dehydration, non-physiological pH,
proteases, complement, and factors of the innate and adaptive
immune systems. In addition to providing protection, core struc-
tural proteins mediate many early host-pathogen interactions that
occur during entry, such as receptor engagement, endocytic signal-
ing, membrane penetration (for non-enveloped viruses), and intra-
cellular capsid transport (Marsh and Helenius, 2006). In some cases,
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capsid proteins also mediate early effector functions to establish an
intracellular environment to facilitate infection (Kelly et al., 2009).
Most virus capsids are assembled from regular capsomere units
resulting in helical or icosahedral structures built from a limited
number of capsid proteins. Inherently, such icosahedral capsids are
highly symmetrical, a property described by the triangulation
number (Caspar and Klug, 1962). In exceptional cases – such as
poxviruses – capsids may be complex in structure being built from a
large number of proteins and lacking symmetry. Regardless of their
architecture, all virus capsids possess a built-in capacity for disas-
sembly, referred to as structural metastability: assembled as stable
structures during morphogenesis inside producer cells, capsids must
be efﬁciently disassembled or disintegrated in newly infected cells.
For some viruses, the environment in which assembly/egress and
uncoating occur are homologous. For instance, herpesvirus uncoating
which involves loss of tegument proteins and capsid transport
towards the nucleus, occurs in the cytosol and at the nuclear pore
(Sodeik et.al, 1997). During tegumentation and egress, newly
assembled capsids are transported through the same cytoplasm
away from the nucleus for secondary envelopment (Mettenleiter
et al., 2009). The ability of viruses to perform such opposing
processes in the same cell compartment has previously been
described as the “assembly-uncoating paradox” (Greber et al., 1994).
In this review, we compare the uncoating and genome delivery
programs of pathogenic DNA viruses of the adeno-, papilloma-,
polyoma-, pox-, and herpesvirus families. The complex disassem-
bly cascades these viruses undergo and the cellular cues to which
they respond are discussed and compared. As genome release is a
critical step in the life cycle of every virus and a prerequisite for
genome replication, understanding the molecular details of viral
capsid disassembly and genome delivery programs may reveal
new drug targets and therapeutic opportunities.
General principles of uncoating
Given the complexity of the genome delivery programwe think
it is beneﬁcial to discuss the terminology used when describing it.
The term “Priming” details the changes to the capsid that occur
prior to productive genome deposition. “Uncoating” on the other
hand speciﬁes the loss of structural proteins from the capsid.
However, both the loss of structural proteins from the capsid as
well as structural rearrangements within it may be considered
priming events, given that they are a prerequisite for successful
genome release. Therefore, “uncoating steps” and “priming steps”
are not mutually exclusive terminologies. Finally, the term “gen-
ome delivery” describes the last step of the entry program when
the genetic information is deposited into the host cell cytosol or
nucleus.
In general, two strategies are used by viruses to mediate genome
release and overcome the “assembly-uncoating paradox”. The capsid
priming strategy and the compartment or milieu strategy (Depicted
in Fig. 1).
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Fig. 1. Capsid priming versus compartment/milieu strategy. Conceptually, virion morphogenesis and uncoating are inverse reactions. The ability of viruses to disassemble
their capsids during entry just hours before thousands of new stable particles are formed has dazzled virologists for years and is hence known as the “assembly-uncoating
paradox”. Viruses have evolved two strategies to avoid this convoluted situation: either a capsid priming strategy (top row) or a compartment/milieu strategy (bottom row).
For each approach both non-enveloped (left) and enveloped (right) viruses are shown. The capsid priming strategy dictates that capsid properties or newly assembled
viruses are altered prior to uncoating (indicated by change in capsid color from red to orange). Alternatively, viruses using a compartment/milieu strategy alter the cellular
environment or resort to distinct cellular compartments (indicated by the change in cytoplasmic color from blue to beige). Thus uncoating and assembly programs occur in
non-homologous cellular environments. Capsid proteins are displayed as triangles, intact capsids as hexagons, and vDNA as curly cues.
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Capsid priming strategy
The capsid priming strategy relies on the capsids undergoing
structural modiﬁcations prior to genome delivery. These can occur
during morphogenesis, when the virus exits the cell, or during
entry before the capsid reaches the preferred site of genome
delivery (Illustrated in Fig. 2). These modiﬁcations increase the
capsids ability to receive speciﬁc cellular uncoating cues, or
facilitate disassembly (structural metastability) of the capsid once
it reaches the environment where genome release is to occur.
Compartment or milieu strategy
Alternatively, viruses using a compartment or milieu strategy
remain structurally sound, but cause a change in the cellular
environment. Altering the environment of the producer cell during
morphogenesis or entry is necessary for viruses that uncoat and
assemble in the same compartment. However, it does require that
the virus devotes a subset of genes for this purpose. Alternatively,
morphogenesis and uncoating may be spatially separated i.e.
require distinct organelles.
In practice, most viruses use a combination of these strate-
gies. Genome uncoating is a complicated multi-step process that
depends on a series of consecutive cues. These often take place
in different subcellular compartments or depend on diverse
host-factors. The nature of these cues can be very diverse and
have recently been classiﬁed as “receptor driven”, “chemical”, or
“mechanical” (Suomalainen and Greber, 2013) (Table 1).
Non-enveloped virus uncoating
The capsids of non-enveloped viruses constitute the outermost layer
of the virion. Thus they are likely to receive uncoating cues within the
extracellular space or upon contact with binding factors and/or
receptors on the cell surface. These capsids protect the viral genome,
determine host tropism, entry pathways, and penetration mechanisms.
Adenoviruses
Adenoviruses feature icosahedral capsids with distinct mor-
phology: capsid faces and edges consist of homotrimeric hexon
protein units, and the 12 vertices are built from penton base
proteins from which ﬁbers extend. In addition, there are four
minor capsid proteins and inner core factors – mostly associated
with the dsDNA genome (reviewed by Russell, 2009).
With regard to genome uncoating of DNA viruses, adenoviruses
– in particular human adenovirus type 2 and type 5 (Ad2/5) – are
the best-studied. These viruses go through a step-wise uncoating
program that begins during virus assembly and proceeds through
distinct disassembly intermediates during the entry process (Greber
et al., 1993). The ﬁrst capsid-priming step occurs during virion
morphogenesis. It is mediated by the virus-encoded protease that
facilitates the transition from immature to mature virions through
proteolytic cleavage (Anderson, 1990; Mangel et al., 2003; Weber,
1976; Webster et al., 1989a, 1998b). Adenovirus particles generated
in the absence of functional protease package the viral genome and
appear morphologically normal (Imelli et al., 2009; Perez-Berna
et al., 2009; Weber, 1976). However they display strong defects in
uncoating and membrane penetration (Greber et al., 1996). This
indicates that proteolytic cleavage serves to prime the virus for
subsequent uncoating cues encoutered during entry. Thus protease
activity is the trigger of virus metastability and must be tightly
regulated. To this end, protease packaged into mature virions is
activated by DNA binding and interaction with the C-terminal
peptide of the protein VI precursor (pVI) (Gupta et al., 2004;
Honkavuori et al., 2004; Mangel et al., 2003, 1993; Webster et al.,
1993). Fully activated protease moves along viral DNA in a one-
dimensional diffusion reaction (sledging) to meet its substrates, all
of which are DNA-associated (Graziano et al., 2013; Mangel and San
Martin, 2014). Later, the protein is inactivated by disulﬁde oxidation
when these virions exit the cell (Greber et al., 1996).
During the entry phase, uncoating of the proteolytically acti-
vated virions begins immediately. At the cell-surface Ad2/5 ﬁber
knobs contact the coxsackie-adenovirus receptor (CAR) (Bergelson
et al., 1997) and Ad2 virion penton-base proteins bind the
adenovirus co-receptor αv-β3/5 integrin (Chiu et al., 1999;
Wickham et al., 1993). Engagement of αv-β3/5 integrin untwists
the pentamer possibly weakening the capsid vertex from which
ﬁbers protrude (Lindert et al., 2009), while the virus-induced
clustering of CAR triggers actin and myosin-2 mediated drifting-
motions (Burckhardt et al., 2011). The coordinate action of CAR
drifting and αv-β3/5 integrin conﬁnement facilitates ﬁber-
shedding. This initial uncoating step, likely mediated by mechan-
ical forces, results in the exposure of the membrane lytic portion
of protein VI during virion endocytosis (Burckhardt et al., 2011;
Wodrich et al., 2010).
Although, low pH was believed to play a key role in the activation
of protein VI-mediated endosomal escape (Blumenthal et al., 1986;
Prchla et al., 1995), recent in-vivo quantiﬁcation of cytosolic particles
suggests that penetration does not depend on endosomal acidiﬁca-
tion (Suomalainen et al., 2013). Thus the molecular cue that times Ad
penetration from endosomes remains to be determined.
Upon penetration, the virus re-encounters reducing conditions
within the cytosol activating the packaged protease. Protease then
cytosol
nucleus
Producer Cell Extracellular Receptor
Endomembrane System Cytosol Nuclear Pore
Fig. 2. Location of capsid priming. “Capsid priming” describes changes that occur to
the capsid prior to successful genome deposition. These changes activate the capsid
to respond to speciﬁc uncoating cues and induce structural meta-stability. Priming
strategies are diverse, and depending on the virus can occur at any time point from
virus assembly to release of the virus genome. Thus priming can occur in many
different locations as displayed: these include priming inside the producer cell
during morphogenesis, in the extracellular space, during interaction with cell-
surface receptors, within the endomembrane system during endocytic trafﬁcking,
in the cytosol, or at the nuclear pore. Priming may involve the loss of structural
capsid proteins or simply rearrangements within or between capsid proteins.
Capsids that have been primed in the various cell locations are shown in orange.
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cleaves inner capsid protein VI-, which sits underneath the vertex
region together with other cementing proteins (Reddy and Nemerow,
2014). This event is thought to free the genome from the inner capsid
wall (Russell and Precious, 1982; Ruzindana-Umunyana et al., 2002).
Thus, protein VI cleavage, the cytosolic uncoating step, is a pre-
requisite for uncoating at the nuclear pore (Greber et al., 1996).
Table 1
Comparison of priming and uncoating strategies used by DNA viruses.
Priming/
Uncoating
Location Trigger/Cue Structural changes/Enzyme activation References
Adenovirus Priming Cytosol/
Producer
cell
Cofactor activation of
protease
Cleavage of protein precursors, minor
structural changes, destabilization of
the capsid
(Anderson, 1990; Gupta et al., 2004; Honkavuori et al.,
2004; Mangel et al., 2003, 1993; McGrath et al., 2003;
Perez-Berna et al., 2009; Perez-Berna et al., 2012; Rancourt
et al., 1995; Weber, 1976; Webster et al., 1993, 1989)
Priming/
Uncoating
Cell
surface
Receptor and co-
receptor engagement
Fiber-shedding, Protein VI exposure (Burckhardt et al., 2011; Lindert et al., 2009)
Priming Cytosol Reducing environment Activation of protease, cleavage of inner
capsid protein VI
(Greber et al., 1996; Ruzindana-Umunyana et al., 2002)
Uncoating Nuclear
pore
Kinesin recruitment to
capsid and Nup358
and activation
Mechanical disruption of the capsid
and nuclear pore components
(Strunze et al., 2011)
Polyomavirus Priming ER Protein disulﬁde
isomerases
Disulﬁde rearrangement, exposure of
VP2/3
(Gilbert et al., 2006; Schelhaas et al., 2007; Walczak and
Tsai, 2011)
Uncoating Cytosol/
Nucleus?
Reducing environment,
low calcium,
chaperones
Loss of pentamers, NLS exposure,
genome exposure?
(Chromy et al., 2006; Inoue and Tsai, 2011; Kuksin and
Norkin, 2012a, b; Li et al., 2009)
Papilloma
virus
Priming Cell
surface
Binding to GAGs of
HSPG
Exposure of a cleft between capsomers
(L1)
(Cerqueira et al., 2013)
Priming Cell
surface
Cyclophilin B
interaction with L2
Exposure of L2 N-terminus including
furin cleavage site
(Bienkowska-Haba et al., 2009; Day et al., 2008)
Priming Cell
surface
Furin Cleavage of L2 N-terminus (Kines et al., 2009; Richards et al., 2006)
Priming/
Uncoating
Endosome Acidiﬁcation/
Cyclophilin B
Segregation of L1 from L2/vDNA
complex, exposure of L2 C-terminus
(Bienkowska-Haba et al., 2012; Campos et al., 2012; Kamper
et al., 2006; Smith et al., 2008)
Priming? TGN / ER Unclear, possibly
disulﬁde reduction/
rearrangement
membrane insertion and penetration? (Campos et al., 2012; Day et al., 2013; Zhang et al., 2014)
Poxvirus Priming Immature
virion/
Producer
cell
Disulﬁde oxidation/
rearrangement.
Possibly
phosphoregulation?
Regulation of transcription machinery? (Liu et al., 1995; Schmidt et al., 2013; Shuman and Moss,
1989)
Priming Endosome Acidiﬁcation Activation of the core? (Schmidt et al., 2013; Townsley and Moss, 2007)
Priming/
Uncoating
“Activation”
Endosome/
cytoplasm
Membrane fusion Loss of LBs, release of
immunomodulators
(Schmidt et al., 2013)
Priming/
Uncoating
“Activation”
Cytoplasm Reducing environment,
other?
Capsid expansion, reduction of capsid
proteins, initiation of transcription
within capsid
(Cyrklaff et al., 2007; Dales, 1963; Locker and Grifﬁths,
1999; Schmidt et al., 2013)
Uncoating Cytoplasm Viral early gene
expression, Cytosolic
proteasomes
D5-recruitment to capsid, D5- and
proteasome-mediated genome release,
Core disintegration or disassembly
(Kates and McAuslan, 1967; Kilcher et al., 2014; Mercer et
al., 2012; Yang and Moss, 2009)
Herpes virus Priming/
Uncoating
Cytosol Membrane Fusion,
Phosphorylation?
Tegument release (Granzow et al., 2005; Maurer et al., 2008; Morrison et al.,
1998a; Morrison et al., 1998b)
Priming Nuclear
pore
Interaction with Nups Docking and positioning of capsid (Copeland et al., 2009; Liashkovich et al., 2011; Trotman et
al., 2001)
Priming Nuclear
pore
Protease Proteolytic cleavage of pUL36 at the
NPC
(Jovasevic et al., 2008)
Uncoating Nuclear
pore
Unknown DNA translocation (requires pUL36 and
pUL25)
(Jovasevic et al., 2008; Liashkovich et al., 2011; Preston et
al., 2008)
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During the course of this cytosolic uncoating step Ad capsids are
transported along microtubules (MTs) to the nucleus (Suomalainen
et al., 1999). Particles dock to the nuclear pore complex (NPC) via
Nup214 (Cassany et al., 2014; Trotman et al., 2001). Capsids are
disassembled and the genomes imported. Like ﬁber shedding,
capsid disassembly is an active process that relies on mechanical
force (Strunze et al., 2011). Kinesin 1 is recruited to the sub-viral
particles via kinesin-light-chain binding to pIX, while kinesin heavy
chain binds nucleoporin Nup358 and activates the motor (Cho et al.,
2009). Consequently, NPC components and sub-viral particles are
pulled towards the plus-end of NPC-proximal microtubules. This
results in mechanical disruption of the subviral particle and break-
down of NPC integrity thereby increasing the permeability of the
nuclear envelope (Strunze et al., 2011).
By this mechanism the viral genome is mechanically uncoated
and nuclear import facilitated. Although a role for classical import
machinery (Greber et al., 1997; Saphire et al., 2000) and molecular
chaperones has been demonstrated (Saphire et al., 2000), the
mechanism of vDNA and associated protein nuclear import remains
incompletely understood.
In sum, adenovirus uncoating relies on multiple priming steps
during morphogenesis, in the extracellular space, upon binding of
their receptors, within endosomes, inside the cytosol, and at the
nuclear pore. For successful genome delivery, such a complicated
process must be highly coordinated both spatially and temporally,
perhaps explaining recent single-genome tracking experiments
which indicate that nuclear import is inefﬁcient with misdelivery
of vDNA to the cytosol being common (Wang et al., 2013a).
Polyoma- and Papillomaviruses
Polyomaviruses (PYs) and Papillomaviruses (PVs) are structu-
rally related non-enveloped viruses with icosahedral capsids
(T¼7) built from 72 pentameric capsomers (Cerqueira and
Schelhaas, 2012). Pentamer units are stabilized by hydrophobic
interactions between major capsid proteins PY VP1 or PV L1, and
strengthened by invasion of the terminal arms of neighboring
pentamers. Disulﬁde bonds between the pentamers are likely
formed after lysis and exposure to the oxidizing extracellular
space. Minor capsid proteins PV VP2/VP3 or PY L2 are located in
the central cavity of the capsomer and are required to incorporate
DNA during morphogenesis. For successful uncoating, these many
capsid-stabilizing interactions need to be altered or broken.
Polyomaviruses
Crystallographic data suggests that PYs do not change their
structure upon contact with receptors (Stehle and Harrison, 1997;
Stehle et al., 1994). This suggests that these viruses, unlike
adenoviruses, are not primed for uncoating at the cell surface.
Upon endocytosis, PYs are routed to the endoplasmic reticulum
(ER) in a receptor-dependent fashion (Engel et al., 2011;
Kartenbeck et al., 1989; Qian et al., 2009). During this journey,
PYs encounter low pH, proteases, and additional endosomal cues
involved in the uncoating of other viruses. However PYs do not
undergo proteolytic cleavage (Jiang et al., 2009; Schelhaas et al.,
2007) and with the exception of BK virus(Jiang et al., 2009),
remain structurally unchanged until reaching the ER.
Most information on the initiation of uncoating within the ER
has been obtained by studies of mouse polyomavirus (mPY) and
simian virus 40 (SV40). In the case of SV40, the protein disulﬁde
isomerase (PDI) ERp57 isomerases disulﬁde bonds that link the
vertex of adjacent pentamers (c9–c9). The isomerization reaction
results in c9–c104 intrachain disulﬁdes, thereby destabilizing the
vertex–pentamer interaction (Schelhaas et al., 2007). Mouse PY uses
a similar strategy but different PDIs (Gilbert et al., 2006; Walczak
and Tsai, 2011). Generally, PYs engage ER chaperones such as ERp57,
ERp29, PDI, BiP, BAP31, and DNAJ family members (Daniels et al.,
2006; Geiger et al., 2011; Goodwin et al., 2011; Magnuson et al.,
2005; Schelhaas et al., 2007; Walczak and Tsai, 2011).
The thiol-disulﬁde oxido-reductases serve to expose the minor
capsid proteins VP2/VP3 whose hydrophobic N-terminus (VP2)
binds to and inserts into the ER membrane (Daniels et al., 2006;
Magnuson et al., 2005). VP2 membrane insertion is required for
initiation of membrane penetration. It was demonstrated that
SV40 recruits the ERAD component BAP31 via a positively charged
residue in the VP2 transmembrane domain that mimics misfolded
membrane proteins (Geiger et al., 2011). The process of transloca-
tion requires both ERAD factors BiP, Bap29, and BAP31 in the case
of SV40 (Geiger et al., 2011; Schelhaas et al., 2007), derlin-2 for
mPY, (Lilley et al., 2006), and cytosolic chaperones (Walczak et al.,
2014). While the mechanism of translocation remains elusive,
interestingly, SV40 has been reported to reach the host cell cytosol
largely intact (Inoue and Tsai, 2011).
Once there, a second major uncoating step occurs during which
the capsid structure is disrupted (Inoue and Tsai, 2011; Kuksin and
Norkin, 2012a). This cytosolic disassembly step culminates in
destabilization of VP1 interchain-disulﬁdes and detachment of
calcium from the capsid. These changes are thought to be assisted
by the reducing conditions and low calcium concentration within
the cytosol. Partial capsid disruption exposes nuclear localization
signals (NLS) in capsid proteins and leads to nuclear targeting of
SV40 subviral particles (Nakanishi et al., 1996).
It has been suggested that polyomaviruses enter the nucleus as
a more or less intact entity (Clever et al., 1991; Yamada and
Kasamatsu, 1993). Yet it is unclear how a 50 nm particle can enter
the nucleus through the NPC that has a size restriction of 39 nm
(Pante and Kann, 2002). Recent data suggests that cytosolic capsid
disassembly is more substantial than previously thought (Inoue
and Tsai, 2011), and that vDNA might enter the nucleus as a
subviral entity devoid of VP2/VP3 proteins (Kuksin and Norkin,
2012a; Kuksin and Norkin, 2012b). As the mechanisms of nuclear
translocation and the conﬁguration/composition of the subviral
structure inside the nucleus is not known, further research will be
required to clarify this last step of polyomavirus uncoating and
nuclear translocation of the genome.
Papillomaviruses
In contrast to PYs, PVs initiate their uncoating program at the
plasmamembrane. For HPV-16 – the most prevalent cancerogenic PV
(Bosch and de Sanjose, 2003) – priming is initiated at the cell surface.
Binding to heparan sulfate proteoglycan (HSPG) receptors initiates
the ﬁrst structural changes within the capsid resulting in the
exposure of an L1 epitope sitting between capsomers (Cerqueira
et al., 2013). The functional consequence of this rearrangement is
currently unclear. However, interaction of the virus capsid with
cyclophilin B – a cell surface peptidylprolyl isomerase – exposes
the N-terminus of L2 (Bienkowska-Haba et al., 2009; Day et al., 2008)
that contains a furin cleavage site (Richards et al., 2006). Subsequent
furin-mediated cleavage of the L2 N-terminus is required for infec-
tion possibly by allowing binding to a secondary, HSPG-independent
receptor. These early priming events have been shown to occur both
in cell culture and in-vivo (Kines et al., 2009; Richards et al., 2006).
After endocytic uptake, PV capsids accumulate in late endo-
somes (Bergant Marusic et al., 2012; Schelhaas et al., 2012). Low pH
serves as an important trigger for additional structural changes
required for uncoating: First, HPV-16 and HPV-33 expose an epitope
normally buried within the capsid (Sapp et al., 1994; Spoden et al.,
2008). Second, the putative membrane-destabilizing L2 C-terminus
(Kamper et al., 2006; Smith et al., 2008) and the viral genome are
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exposed (Campos et al., 2012). This is the most dramatic uncoating
step in the life cycle of PVs as it leads to substantial segregation of
L1 from the L2/vDNA complex. However, capsids do not appear to
be completely disassembled at this stage, as they can be visualized
in lysosomal compartments late during infection (Schelhaas et al.,
2012). Low pH is likely the key player in this process as exposure of
PV virions to low pH in-vitro increases the accessibility of the
genome to DNAseI (Smith et al., 2008) and endosomal proteases
such as the cathepsins do not seem to play a role in uncoating
(Dabydeen and Meneses, 2009; Richards et al., 2006).
While the mechanism of L1/L2 vDNA segregation is not known,
the viral DNA and L2 (as well as small amounts of L1 (DiGiuseppe
et al., 2014)) are transported to the trans-golgi network (TGN) (Day
et al., 2013). Golgicide A treatment blocks infection and leads to
the accumulation of the pseudogenome in late endosomal com-
partments (Day et al., 2013). It was recently shown that the
endosome to TGN transition requires the activity of the cellular
membrane-associated protease γ-secretase (Karanam et al., 2010;
Zhang et al., 2014). Interestingly, γ-secretase does not cleave
structural proteins of the capsid, but rather an unknown cellular
substrate required for endosome-to-TGN transport. Hence this
protease is required for proper trafﬁcking rather than uncoating.
How and where penetration of PY viruses occurs is unclear.
Experimental evidence suggests that a recently identiﬁed NLS and
the putative membrane lytic c-terminus of L2 are required
(DiGiuseppe et al., 2014; Kamper et al., 2006; Mamoor et al.,
2012). Another model suggests that an N-terminal L2 transmem-
brane domain facilitates membrane insertion and penetration
(Bronnimann et al., 2013). The requirement of a cellular reductase
and/or PDIs for penetration has been demonstrated (Campos et al.,
2012) and an intramolecular disulﬁde-bond important for pene-
tration is in proximity of the L2 N-terminal motif (Campos and
Ozbun, 2009). In support of this, proximity ligation assays of
incoming L2 suggest that the subviral complex enters the ER and
interacts with ER-resident BiP and PDI (Zhang et al., 2014). Even
though the molecular mechanism of penetration is unclear, it is
likely that the subviral particle undergoes additional structural
changes within the TGN or ER that render it competent for L2
membrane insertion and subsequent translocation of the L2/vDNA
complex. Thus, it is likely that TGN – which is absolutely required -
and ER-resident cellular proteins are involved in this step of
uncoating explaining the need to pass through these compart-
ments. Such a mechanism would share conceptual similarity with
the ER-mediated uncoating of polyomaviruses.
Once in the cytoplasm, vDNA and L2 are transported into the
nucleus (Day et al., 2004). This requires host cell progression through
early mitosis as the L2/vDNA complex can only access its ﬁnal
destination during nuclear envelope breakdown (NEB) explaining
why only mitotic cells are infected (Aydin et al., 2014; Pyeon et al.,
2009). While transport through nuclear pores is not involved (Aydin
et al., 2014), direct transport through the ER to the nucleus has been
suggested as an alternative model (Zhang et al., 2014).
In sum, PV are primed for uncoating through a number of
conformational changes at the PM followed by substantial
endosome-mediated uncoating. Upon transport of the L2/vDNA
complex to the TGN and ER, additional undeﬁned disassembly steps
or rearrangements may occur leading to translocation of the
subviral complex to the cytosol. It is not clear whether further
uncoating steps occur in the cytoplasm or during nuclear entry.
What is clear is that in contrast to PYs, PVs undergo major
uncoating steps before accessing the cytoplasm (Merle et al.,
1999). Such a strategy is somewhat surprising – especially con-
sidering the fact that the viral DNA may be required to wait for NEB
for a considerable amount of time without its protective capsid. It
will be of interest to address how the L2/vDNA complex can avoid
detection by cytosolic innate DNA-sensors prior to gaining access to
the nucleus. Direct penetration from the ER into the nuclear
compartment during NEB would be an attractive model but has
yet to be experimentally addressed.
Enveloped virus uncoating
Unlike non-enveloped virus capsids, enveloped virus capsids
cloaked by a lipid membrane are not directly exposed to uncoating
cues during spread from one cell to another or during transit
within the endosome system. Thus, capsids of enveloped viruses
have fundamentally different roles from those of non-enveloped
viruses in that they mostly respond to uncoating cues after fusion.
Poxviruses
Pox virions are large, barrel-shaped particles that contain a
complex, proteolytically-processed, disulﬁde-linked, dumbell-
shaped capsid – generally referred to as the virus core. It is ﬂanked
by two proteinaceous lateral bodies (LBs) which ﬁll the concavities
between core and membrane. The core contains the 200 kb dsDNA
genome and is composed of at least 47 structural proteins and
core enzymes (Condit et al., 2006; Moss, 2007). Vaccinia virus
(VACV), the model poxvirus and variola vaccine has been studied
most intensively and we will therefore focus exclusively on VACV
uncoating.
As poxvirus genome-release and replication occur in the cyto-
plasm, these viruses face particular challenges related to innate
DNA-sensing and antiviral response. As a consequence, they have
evolved a highly regulated, multi-step core-disassembly program.
Elegant biochemical studies in the 1960s demonstrated that pox-
virus uncoating is a two-step process (Joklik, 1964a, 1964b): The
ﬁrst stage commences immediately after membrane fusion and is
referred to as “core activation”, the second stage, cytoplasmic
genome release, occurs after a lag-period due to the requirement
for expression of a virus-encoded uncoating protein (Joklik, 1964a,
1964b; Kates and McAuslan, 1967; Prescott et al., 1971).
Structural changes within the core prior to the fusion of the
VACV membrane have not been described. However, there is
indirect evidence that the capsid may be modiﬁed as macropino-
somes are acidiﬁed during endocytosis (Schmidt et al., 2012): Pre-
treatment of virus with pH 5 prior to adsorption enhances the
kinetics of infection without by-passing the need for endosomal
acidiﬁcation and fusion (Townsley and Moss, 2007). This suggests
that VACV entry involves two acid-dependent steps. More
recently, the presence of a proton channel in the mature virion
(MV) membrane was proposed based on the observation that
ﬂuorescence of EGFP-cores in intact MVs was reversibly quenched
when exposed to low pH (Schmidt et al., 2013). The identity of this
channel is unknown and its existence therefore speculative.
However, it is conceivable that pre-fusion acidiﬁcation might
prime the core for efﬁcient uncoating or early transcription. Such
a function has recently been described for the proton channel of
inﬂuenza virus (Stauffer et al., 2014).
Immediately upon fusion cores undergo dramatic morphologi-
cal changes (Dales, 1963; Schmidt et al., 2013). Cores expand and
change from biconcave to oval shape, leaving behind the two LBs
at the endosomal membrane where fusion occurred (Cyrklaff et al.,
2007; Dales, 1963; Hollinshead et al., 1999; Schmidt et al., 2013).
During this “core activation” step, disulﬁde-bonds within and
between core structural proteins 4a, 4b, possibly VP8, and the LB
scaffold protein F17 are reduced. In vitro studies have identiﬁed
additional disulﬁde-bonded core proteins that may be reduced
in-vivo as well (Locker and Grifﬁths, 1999; Schmidt et al., 2013).
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VACV cores can be generated in-vitro by treating MVs with NP-40
and reducing agent. With the exception of a lack of LB detachment,
this treatment leads to similar morphological changes as observed
during activation in vivo. This suggests that entry into the reducing
cytoplasm is the trigger for activation. However, that in vitro lipid-
solubilization and reduction is not sufﬁcient to detach LBs suggests
their removal depends on fusion (Easterbrook, 1966; Schmidt et al.,
2013).
Released VACV cores have the unique ability to produce early
viral transcripts prior to their disassembly. Early gene transcription
and mRNA export from cores is initiated immediately after fusion
via the action of viral RNA polymerases and transcription factors
that are pre-bound on early promoters inside the core (Kates and
McAuslan, 1967; Yang and Moss, 2009). As early viral gene
expression is an absolute pre-requisite to initiate the second phase
of uncoating, the activation of the transcription machinery must
be considered a priming step.
Two RNA polymerase subunits are disulﬁde-bonded in MVs
(Schmidt et al., 2013) making it tempting to speculate that
disulﬁde reduction during activation triggers early transcription.
Supporting this, early transcription from VACV MVs can be
induced artiﬁcially in the presence of NP-40, dithiothreitol (DTT),
and nucleotides (Shuman and Moss, 1989). In addition to reduc-
tion, experimental evidence suggests that the early transcription
machinery may be regulated by phosphorylation. VACV packages
both a kinase (F10) and a phosphatase (H1)(Liu et al., 1995; Szajner
et al., 2004), and phosphatase-deﬁcient particles are defective for
early gene transcription (Liu et al., 1995).
As a consequence of activation, a set of early viral transcripts are
released from the core and translated on host ribosomes. How viral
transcripts leave the core to initiate the second phase of uncoating
is not known. Cryo-electron tomography suggests the presence of
pore-like structures with a diameter of 7 nm through which the
viral mRNA could potentially escape (Cyrklaff et al., 2005). Without
these early gene products, the uncoating program arrests, cores
accumulate in the cytoplasm (Dales, 1965), and the viral DNA
remains inaccessible to DNAseI in cell lysates (Joklik, 1964b).
Collectively, this early data from the 1960s suggested the
existence of a viral “uncoating protein” (Joklik, 1964a, 1964b).
Recently, the primase/helicase protein D5 was identiﬁed as the
viral uncoating factor (Kilcher et al., 2014). In the absence of newly
synthesized D5 the viral genome remains inaccessible to cytosolic
enzymes and does not leave the cores, which remain in the cytosol
as stable structures. The molecular mechanism of D5-mediated
genome release remains unclear. However, super-resolution micro-
scopy showed that D5 localizes to distinct lateral subdomains of
incoming cores suggesting a deﬁned exit portal for the viral DNA
exists. As the replicative helicase, D5 is also required for DNA
replication (Boyle et al., 2007; De Silva et al., 2007; Evans et al.,
1995) albeit with different enzymatic requirements: the C-terminal
AAAþ ATPase domain – a putative SFIII helicase – is required for
both uncoating and replication of the genome, whereas the
N-terminal primase is dispensable for uncoating (Kilcher et al.,
2014). The involvement of a hexameric ring-like AAAþ ATPase
(Boyle et al., 2007; Sele et al., 2013) in uncoating suggests that
mechanical force or major structural rearrangements are required
for genome release. Whether D5 destabilizes the capsid structure
or actively removes the genome from a portal remains to be
determined.
Previously, it was assumed that expression of the viral uncoating
protein would be sufﬁcient to release the genome. Thus, a possible
contribution of cellular proteins was not addressed. Recent studies
demonstrated that host proteasome activity was also required for
core degradation and genome release. In the presence of protea-
some inhibitors, the uncoating factor D5 is expressed. However,
viral cores are not disassembled (Mercer et al., 2012), genomes
remain protected, and do not disassociate from cores (Kilcher et al.,
2014). As new ubiquitination is not required and core proteins are
packaged in an ubiquitinated state, we speculate that proteasomes
act directly on core proteins (Mercer et al., 2012). As both protea-
somes and D5 are necessary, but not sufﬁcient, to mediate uncoat-
ing, investigation of the interplay between D5 and proteasomes will
hopefully shed light on these ﬁnal steps of poxvirus genome release.
Herpesviruses
Herpesviruses are a family of large, enveloped, linear dsDNA
viruses with distinct morphology. An icosahedral capsid contain-
ing the genome is surrounded by a layered multi-protein assem-
bly, the tegument, and enclosed within the virus proteolipid
membrane. Most information on herpesvirus uncoating was
obtained using the alphaherpesvirus, herpes simplex virus 1
(HSV-1). Given the diversity of HSV-1 cell-type and virus-speciﬁc
entry pathways and that no changes to the tegument or capsid
prior to fusion have been reported, only post-fusion events will be
discussed here.
Concomitant with fusion, tegument proteins are released into
the cytosol (Maurer et al., 2008). The mechanism by which this
occurs is not understood. Although not essential in cell culture
(Coulter et al., 1993; Purves et al., 1987), in-vitro, tegument
dissociation depends on the kinase activity of tegument resident
kinases pUL13 and pUS3 (Morrison et al., 1998a, 1998b). Uncoated
capsids and remaining associated inner tegument are transported
along microtubules (MTs) in a dynein-dependent manner (Sodeik
et al., 1997). The outer capsid protein pUL35 (Desai et al., 1998;
Douglas et al., 2004), inner tegument proteins (Wolfstein et al.,
2006), tegument protein pUL14 (Yamauchi et al., 2008) and ICP0
(Delboy and Nicola, 2011) facilitate targeting to the nuclear pore,
where nucleocapsid uncoating occurs.
For HSV-1, binding to the NPC requires imortin β and a functional
RanGTP/GDP cycle (Ojala et al., 2000). Capsid proteins pUL25
(Pasdeloup et al., 2009) and pUL36 (Copeland et al., 2009) have been
implicated in mediating the interaction of nucleocapsids with
nuclear pore protein Nup214 and NPC ﬁlament protein Nup358.
While some of the players involved in genome uncoating at the
nuclear pore are known, the mechanism is poorly understood.
Temperature-sensitive mutants of pUL25 (Preston et al., 2008) and
pUL36 (Jovasevic et al., 2008) dock to the NPC, but fail to release
their genome. This suggests that their role in NPC docking and
uncoating can be separated.
Although proteolytic cleavage of pUL36 at the NPC seems to be
required for uncoating in-vivo (Jovasevic et al., 2008), the trigger of
DNA release is currently unknown (Liashkovich et al., 2011).
In-vitro, genome release can be provoked in the presence of
guanidine-hydrochloride (Newcomb and Brown, 1994) or by heating
of isolated capsids (Newcomb et al., 2007). Capsids also uncoat in the
presence of isolated nuclei, cytosolic extract, and an ATP regenerating
system (Ojala et al., 2000). Similar to phage DNA ejection, the genome
is likely translocated in a polarized fashion (Newcomb et al., 2009),
although other mechanisms have been proposed (Shahin et al., 2006).
The driving force for DNA translocation is not currently known,
but several models have been suggested (reviewed in Liashkovich
et al., 2011). These include: pressure-driven release, passive
ratchet-like diffusion, crowding effects, and a pull-in mechanism
involving transcribing RNA-polymerases, akin to T7 bacteriophage
(Kemp et al., 2004). In vitro studies indicate that the genome exits
the capsid through the packaging portal (Newcomb et al., 2009),
which is likely to hold true in-vivo as well. To this end, the portal
protein pUL6 that sits at one deﬁned capsid vertex (Cardone et al.,
2007; Chang et al., 2007), may be important for DNA translocation.
In addition to providing the translocation channel, it could also
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provide for proper orientation of the capsid on the NPC
(Liashkovich et al., 2011).
In sum, the combination of in vitro and in vivo studies have
provided insight into viral and cell factors required for herpesvirus
uncoating. Further work should seek to deﬁne the role of tegu-
ment, if any, additional cell factors, and the mechanism by which
the genome is translocated from the capsid.
Uncoating and innate sensing of DNA
Not surprisingly, the host immune system has evolved numer-
ous strategies to interfere with the process of virus genome
uncoating. TRIM5α, for example, was discovered as an innate
restriction factor that counteracts infection of Old World Monkeys
by HIV-1. TRIM5α binds incoming capsids directly and leads to
their premature fragmentation in a proteasome-dependent or
independent manner (Malim and Bieniasz, 2012; Nakayama and
Shioda, 2010).
Proper timing of DNA release is an important aspect of the virus
disassembly program. Premature DNA release not only leads to
abortive infection due to genome misdelivery, but also exposes
viral nucleic acids to pattern recognition receptors (PRRs) of the
innate immune system.
Recently, many DNA-speciﬁc PRRs have been identiﬁed and
characterized. These include members of the Toll-like receptor
family that survey the endosomal space (reviewed by Wu and
Chen, 2014). Cytosolic detection of DNA is mediated by several
pathways including: RNA polymeraseIII/RIG-I, cGAS/STING/TBK1,
or the other putative cytosolic sensors DAI, IFI16, DDX41, and DNA-
PK (Wu and Chen, 2014). Many of these sensor-pathways converge
upon activation and nuclear translocation of interferon regulatory
factors IRF-3, IRF-7, and of NF-κB. Subsequent transactivation of
type I interferons and other interferon-inducible genes promote an
antiviral state. In some cell types including macrophages, cytosolic
DNA is sensed by AIM2 leading to inﬂammasome assembly.
Subsequently, interleukins (IL-1β and IL-18) are activated and
released (Hornung and Latz, 2010; Wu and Chen, 2014).
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In turn, many viruses have evolved effector proteins to block the
function of key players within these pathways. It reasons, that the
earlier viruses counteract innate immune signaling, the more likely
they are to avoid induction of an antiviral state. Thus, most viral
innate effectors are expressed during an early phase of infection.
However, the ideal strategy would be to counteract innate
sensing prior to genome release. This can be achieved when capsid
or capsid-associated proteins that are released from incoming
virions exert immediate effector function. In such a scenario, the
uncoating program and the subversion of innate sensing pathways
would be mechanistically linked. There is currently no evidence
supporting such a mechanism for any of the non-enveloped DNA
viruses. For enveloped viruses however, immediate effector func-
tions have been demonstrated and we will therefore focus on
herpesviruses and poxviruses in the next section.
DNA sensing of herpesviruses involves TLR9 (Krug et al., 2004a,
2004b; Lund et al., 2003), IFI16, and STING. Sensing can occur in
both the cytosol and in the nucleus of infected cells (Horan et al.,
2013; Li et al., 2012). Alphaherpesvinae package around 20
tegument proteins (Kelly et al., 2009; Loret et al., 2008), eight of
which have ascribed immune-modulatory functions. HSV-1 tegu-
ment proteins pUL13, pUL48 (VP16), and ICP0 all interfere with
IRF-3 function through direct binding, which leads to sequestra-
tion of nuclear IRF3 (Orzalli et al., 2012) or inhibition of IRF3
interaction with its transcriptional co-activator CBP (Hwang et al.,
2009; Xing et al., 2013).
Tegument proteins ICP34.5 and pUL36 target TBK1. ICP34.5
disrupts the interaction of TBK1 with IRF-3 to prevent STING
dependent type I interferon responses (Abe et al., 2013; Verpooten
et al., 2009), whereas pUL36, deubiquitinates TRAF3 preventing
the recruitment of TBK1 (Wang et al., 2013b).
NF-κB activation is targeted by tegument proteins pUL41
(Cotter et al., 2011; Suzutani et al., 2000) and pUL48 (Xing et al.,
2013) and US3 was shown to interfere with NF-κB and IRF-3
activation downstream of TLR signaling (Peri et al., 2008; Sen et al.,
2013). An additional HSV tegument protein targets the RIG-I
pathway: US11 physically interacts with endogenous RIG-I and
MDA5 to prevent interaction with MAVS. Thereby it blocks down-
stream activation of IRF-3 and subsequent IFNβ production (Xing
et al., 2012). For these experiments, innate sensing was activated
by Sendai virus infection. It remains unclear whether this mechan-
ism also contributes to HSV pathogenesis. Lastly, ICP0 appears to
interfere with the IFI16 DNA-sensing pathway preventing HSV-1-
induced IFNβ induction. While the exact mechanism is still
controversial it seems to involve IRF-3 and IRF-7 (Lin et al.,
2004; Melroe et al., 2004; Orzalli et al., 2012; Paladino et al., 2010).
The presence of such a large number of immune-modulators
indicates that DNA sensing is an important hurdle for herpes-
viruses to overcome. As such, these tegument proteins are not only
delivered by incoming virus, but produced early during viral
infection. It is generally assumed that incoming tegument protein
is not a major contributor to immune evasion since cells infected
with UV-inactivated herpesvirus, or in the presence of cyclohex-
imide or actinomycinD induce the expression of interferon-
responsive genes (Nicholl et al., 2000; Preston et al., 2001).
While this data demonstrates the need for sustained expression
of these effectors, it does not exclude the importance of their delivery
as components of the tegument. Immediate effector delivery may
serve as a ﬁrst line of defense, used to hold back the innate immune
response until immediate early genes are expressed. To assess this
experimentally, the innate responses to UV-inactivated virus in the
presence or absence of speciﬁc tegument proteins would need to be
compared.
An interesting recent example of this is the tegument protein
pUL83 of human cytomegalovirus (HCMV). UL83 interacts with
IFI16, inhibits its oligomerization, and thereby prevents antiviral
response via STING-TBK1-IRF-3. UV-inactivated ΔUL83 virus
induces a three-fold increase in the production of IFNβ compared
to wt UV-inactivated virus, demonstrating a direct role of this
tegument protein in supressing cellular innate immune responses
(Li et al., 2013).
In contrast to herpesviruses, poxviruses release and replicate
their genome in the cytosol. Given this exposure of a large amount
of DNA, it comes as no surprise that poxviruses encode a handful
of proteins to counteract DNA sensing, TLR-, and interferon-
signaling pathways. The VACV strain western-reserve strain
encodes no less than 31 immune modulators (recently reviewed
by Smith et al., 2013). With regards to cytosolic DNA sensing, they
target IRF-3, NF-κB, RIG-I/MAVS, and DNA-PK (Smith et al., 2013).
As we have discussed in the uncoating section, poxviruses are
unique in their ability to express early genes from the intact viral core.
By expressing both the viral uncoating protein and the majority of
immune modulators from early promoters, VACV ensures that gen-
omes are not exposed before the encoded immune evasion factors
disable immune signaling pathways. Uncoating and immune evasion
are therefore synchronized by the early gene-transcription machinery.
In addition to these early effectors, the virus has evolved an
immediate-early strategy analogous to the herpesvirus tegument. The
virion-associated phosphatase, VH1, was shown to dephosphorylate
p-STAT1 andmitigate interferon-γ responses (Mann et al., 2008; Najarro
et al., 2001). While VH1-mediated immune modulation was found to
depend on virus uncoating, it was independent of early gene expression
(Najarro et al., 2001). This ﬁnding suggested that VH1 associated with
incoming virions was responsible for this action. Recently, the mechan-
ismwas solved: VH1 is packaged inside the VACV lateral bodies (LBs) as
an effector protein, which is released upon degradation of LB scaffold
protein F17 (Schmidt et al., 2013). Since LB disassembly and VH1-
mediated inhibition of STAT1 nuclear translocation depend on protea-
some function, the authors hypothesize that VH1 is activated by
proteasome-mediated release from LBs. Whether VACV delivers addi-
tional immune effectors by this mechanism remains to be determined.
Given their large size and unusual virion structure, herpes- and
poxviruses are able to store a considerable amount of protein
outside the capsid that can be deposited into the host cytosol
immediately after fusion. Whether smaller, non-enveloped DNA
viruses package and subsequently deliver viral immune effectors
remains to be determined.
Conclusions and outlook
The primary goal of all viruses is to deliver a replication
competent genome to the right cellular location at the right time.
The examples discussed here highlight the various spatial/tem-
poral strategies employed by adeno-, papilloma-, polyoma-, pox-,
and herpesvirus families to assure successful infection (Illustrated
in Fig. 3). As metastable particles, viruses are like puzzle boxes, in
which each step of the uncoating program is required for the next.
The cell unwillingly and unknowingly solves the puzzle as cellular
endocytosis and trafﬁcking machineries move the virus closer to
its preferred site of genome release.
While much is known about the uncoating programs used by
these pathogens, there remains a major gap in our mechanistic
understanding of genome translocation from the capsid. In light of
the assembly-uncoating paradox, it will also be important to begin
investigation of the link between viral morphogenesis and uncoat-
ing. Not only to uncover additional cell and viral factors that
contribute to the solution of this paradox, but to deﬁne how capsid
metastability is ‘built in’ to virus capsids.
Finally, amantadine – a selective inhibitor of the inﬂuenza virus
M2 channel – blocks uncoating of certain inﬂuenza strains and has
long been used as an FDA approved anti-inﬂuenza drug before
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most strains developed resistance (Ison, 2011; Maugh, 1976). Thus,
given the number of steps involved in the uncoating of each of
these viruses, it will be of interest to explore novel antiviral
strategies that target virus uncoating.
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